Latest UK News
The study from the MRC LMB published in the journal Cell is the first to identify insulin as a primary signal that helps communicate the timing of meals to the cellular clocks located across our body, commonly known as the body clock.
The MRC’s 2019 Max Perutz Science Writing Award is now open.
Around four million people in the UK carry genetic variants that protect them from obesity, type 2 diabetes and heart disease, according to a new paper co-authored by MRC researchers.
Professor Dame Anna Dominiczak has been appointed as MRC Health Innovation Champion.
MRC scientists have isolated therapeutic antibodies from healthy volunteers exposed to the Ebola vaccine but not Ebola virus itself, suggesting that protective therapies could be developed from people who are disease-free.
By building capacity and capability in public health research, a report shows how the legacy of a UK-wide network of centres of excellence has helped fuel future public health and prevention research.
Cutting edge projects have received £23 million of government funding under the Biomedical Catalyst, it was announced today. The MRC invested nearly £13.5 million in a number of innovative projects.
MRC Laboratory of Molecular Biology researchers reveal atomic structures of the abnormal tau filaments associated with chronic traumatic encephalopathy, a head injury-associated neurodegenerative disease, differ in structure from those seen in Alzheimer’s disease.
A nine to 11-month treatment regimen is as effective in treating multi-drug resistant tuberculosis (MDR-TB) as the 20 to 24-month regimen recommended in 2011 WHO guidelines, according to new research conducted by a team of researchers, including MRC scientists.
A vast tranche of new UK Biobank genetic data becomes available to health researchers today, offering an unprecedented resource to enhance understanding of human biology and aid in therapeutic discovery.
The debilitating behaviours and all-consuming thoughts, which affect people with severe obsessive compulsive disorder (OCD), could be significantly improved with targeted deep brain stimulation, according to the findings of an MRC-funded study.
Factors that influence the health of our blood vessels, such as smoking, high blood pressure, obesity and diabetes are linked to less healthy brains, according to new research part-funded by the MRC.
Scientists have found a potential new drug for treating the heart damage caused by a heart attack by targeting the way the heart reacts to stress, according to new research which used stem cells to grow heart tissue and mimic a heart attack in a dish.
A second person has experienced sustained remission from HIV-1 after ceasing treatment, according to new research part-funded by the MRC.
New research has found a novel way to predict rejection of a kidney transplant before it happens by monitoring the immune system of transplant patients.
Professor Patrick Chinnery has been appointed as MRC Clinical Director. He joins the senior management team and will play a key role in developing, promoting and implementing MRC research programmes, working with national and international partners.
Researchers reveal findings that explain why some people who have never smoked develop chronic obstructive pulmonary disease.
Distortions to DNA, which occur routinely during gene expression and other cellular processes, could lead to off-target changes to the genome when using CRISPR-Cas9, a new study suggests.
MRC-funded research from King’s College London suggests one in 13 young people in the UK have had post-traumatic stress disorder (PTSD) before reaching age 18.
Parliamentarians, researchers, policy makers, industry figures and funders discussed research progress against AMR, outstanding research priorities and what is needed to enable research to deliver a step-change in tackling AMR.